Last updated on April 24, 2014 at 21:24 EDT

Elsevier Launches New Open Access Journal in Biomedicine: Journal of Clinical and Translational Endocrinology

September 12, 2013

NEW YORK, September 12, 2013 /PRNewswire/ –

Elsevier [http://www.elsevier.com ], a world-leading provider of scientific, technical
and medical information products and services, is pleased to announce the launch of a new
open access research publication – Journal of Clinical and Translational Endocrinology
(JCTE). [http://www.jctejournal.com ]

The scope of this new journal is patient-oriented research in a variety of disciplines
in endocrinology, including diabetes, metabolic bone disease and osteoporosis, thyroid
disease, pituitary and lipid disorders. Areas of high priority include novel
pilot/proof-of-concept clinical trials in humans and basic science research involving
human specimens.

Dr. Vin Tangpricha from Emory University, Atlanta, Editor-in-Chief of the journal,
said, “Journal of Clinical and Translational Endocrinology will provide authors a unique
home for manuscripts focused on patient-oriented endocrinology research that translates
basic science research to clinical applications for patients with endocrine diseases. As a
practicing clinician and a researcher in endocrinology, I understand the importance of
strengthening the relationship between the clinical and basic sciences. We look forward to
providing the scientific community with high-yield content that addresses the needs of
readers and investigators interested in translational research of endocrine diseases.”

Andrew Miller, Executive Publisher at Elsevier, added, “Journal of Clinical and
Translational Endocrinology will offer the research community a unique and dynamic blend
of tradition and innovation: editorial review from an expert team of researchers together
with our publishing and dissemination systems, involving innovative, digital approaches.
Elsevier is very pleased to launch JCTE and work with Dr. Tangpricha and the journal
editors to serve the needs of endocrinologists internationally.”

For more information or to submit an article, go to: www.JCTEjournal.com
[http://www.jctejournal.com ]. The journal is ready to accept submissions.

About the Editor-in-Chief: Dr. Vin Tangpricha, MD, PhD

Dr. Vin Tangpricha is an Associate Professor of Medicine at Emory University School of
Medicine in the Division of Endocrinology, Metabolism and Lipids. He received his M.D. at
Tufts University and completed his internal medicine residency and endocrinology
fellowship at Boston University Medical Center. He completed a PhD in Molecular Medicine
on the topic of colon cancer and vitamin D. Dr. Tangpricha has published a number of
manuscripts investigating the role of vitamin D in patients with chronic kidney disease,
cystic fibrosis, and infections including HIV and TB. He is currently conducting a number
of clinical trials to translate findings from the bench that suggest that vitamin D may
play an important role in improving outcomes in patients with infections.

About Open Access Publishing at Elsevier

Elsevier has been providing open access publishing options since 2005. Today,
researchers can choose to publish open access in over 1,600 established peer-reviewed
journals as well as 52 full open access journals and these numbers will continue to grow
rapidly. All of Elsevier’s open access publications have been peer reviewed, ensuring that
the broader community not only reads the latest research but that it is factual, original
and of the highest quality and ethical standards. For more information about Elsevier’s
open access program, visit www.elsevier.com/openaccess [http://www.elsevier.com/openaccess

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information
products and services. The company works in partnership with the global science and health
communities to publish more than 2,000 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and close to 20,000 book
titles, including major reference works from Mosby and Saunders. Elsevier’s online
solutions include ScienceDirect [http://www.sciencedirect.com ], Scopus
[http://www.scopus.com ], SciVal [http://info.scival.com ], Reaxys
[http://www.elsevier.com/reaxys ], ClinicalKey [https://www.clinicalkey.com ] and Mosby’s
Suite [http://www.confidenceconnected.com ], which enhance the productivity of science and
health professionals, helping research and health care institutions deliver better
outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier [http://www.elsevier.com ]
employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc
[http://www.reedelsevier.com/Pages/Home.aspx ], a world leading provider of professional
information solutions. The group employs more than 30,000 people, including more than
15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies,
Reed Elsevier PLC and Reed Elsevier NV.

Their shares are traded on the London, Amsterdam and New York Stock Exchanges using
the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.

        Media contact
        Brant Emery

SOURCE Elsevier

Source: PR Newswire